Biotechnology entrepreneur brings more than 25 years of life sciences and commercialization experience to Oregon’s statewide innovation initiatives.
Bend, Oregon — 30th October 2026 — HepaTx Corporation, a biotechnology company developing investigational cell therapies for serious liver disease, today announced that its Founder and Chief Executive Officer, Eric Schuur, PhD, has been appointed by the Governor of Oregon to the Oregon Innovation Council (Oregon InC).
Oregon InC is a public-private partnership that supports the commercialization of new technologies and oversees Business Oregon’s innovation programs. Guided by Oregon’s 10-Year Innovation Plan, the council supports innovation-based businesses, entrepreneurship, and economic growth across the state.
Dr. Schuur brings more than 25 years of experience building and advising emerging life sciences companies, with expertise spanning regenerative medicine, gene therapy, diagnostics, and oncology. At HepaTx, he leads the development of investigational cell therapies intended to address serious liver disease.
His experience also includes advising Stanford School of Medicine’s SPARK program and serving as a director of the StartX ...